Join
Live feed
·
PRReleasevia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving 98% Total Revenue Growth Year-over-Year

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.